Pozen Inc $8.70

down -0.03


17/4/2014 08:10 PM  |  NASDAQ : POZN  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get POZN Trend Analysis - it has outperformed the S&P 500 by 58%

Partner Headlines

  1. Pozen Submits Final Study Report for PA8140/PA32540 Phase 1 Study on Schedule

    Benzinga
  2. Top 4 Small-Cap Stocks In The Drug Manufacturers-Other Industry With The ...

    Benzinga
  3. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
  4. Morning Market Losers

    Benzinga
  5. Benzinga's Top #PreMarket Losers

    Benzinga
  6. Benzinga's Top Downgrades

    Benzinga
  7. POZEN New PA8140/PA32540 PDUFA Date is April 25, 2014

    Benzinga
  8. POZEN Announces December 31, 2013 as Ex-Dividend Date for Previously Announced ...

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. POZEN Announces Special Cash Distribution of $1.75/Share

    Benzinga
  11. Horizon to Acquire US Rights for VIMOVO from Pozen

    Benzinga
  12. Benzinga's Top Pre-Market Gainers

    Benzinga
  13. Stocks To Watch For September 5, 2013

    Benzinga
  14. SANOFI

    IBD
  15. Sanofi, Pozen Announce Exclusive License Deal for Commercialization of ...

    Benzinga
  16. Pozen Inc. Reports Operating Results (10-Q)

    GuruFocus
  17. UPDATE: Ascendiant Capital Markets Initiates POZEN at Buy; Future Royalties ...

    Benzinga
  18. POZEN Announces PA32540 Provides Superior Antiplatlet Effects over a Standard ...

    Benzinga
  19. POZEN Provides Positive Update on Its PA Program and Results of Its Type ...

    Benzinga
  20. POZEN Receives Patent on PA Products for Treatment of Cardiovascular Disease ...

    Benzinga
  21. Celgene, Bed Bath & Beyond Among Stocks Gapping Down Thursday

    FoxBusiness
  22. Morning Market Losers

    Benzinga
  23. POZEN Says FDA Does Not Agree That BioEquivalence Was Demonstrated

    Benzinga
  24. POZEN Announces Licensing Deal with Desitin Arzneimittel GMBH for MT 4 ...

    Benzinga
Trading Center